New cell therapy trial hopes to tackle tough cancers
Disease control
Recruiting now
This early-phase trial tests SL-28, a cell therapy made from donor immune cells, in 60 people with advanced solid tumors (like lung, pancreatic, or breast cancer) that haven't responded to standard treatments. The study aims to find a safe dose and see if the therapy can shrink t…
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC